ArticleFrontiers in plant science2026
AI-enhanced framework for optimizing CRISPR-Cas gene editing in crop biotechnology addressing regulatory challenges and opportunities in global agricultural practices.
Article in Frontiers in plant science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The integration of CRISPR Cas genome editing with artificial intelligence (AI) offers significant potential for crop biotechnology by supporting more precise and adaptive strategies for trait improvement under complex agricultural and regulatory conditions. However, the global governance of gene edited crops remains highly heterogeneous, creating major challenges for the development of frameworks that can jointly support optimization, uncertainty management, and regulatory alignment. Conventional approaches often lack the ability to account for evolving regulatory requirements and multi source uncertainties in a unified manner. Methods: In this paper, we introduce the Adaptive Regulatory Optimizer (ARO), an AI enhanced framework designed to support CRISPR Cas genome editing in crop biotechnology under biologically, regulatorily, and contextually constrained conditions. The ARO consists of three interconnected modules: the Manifold Constrained Gene Editor, the Agent Driven Regulatory Planner, and the Uncertainty Propagation Filter. Together, these modules embed editing decisions within biologically feasible manifolds, incorporate jurisdiction aware regulatory planning, and model interacting uncertainties associated with gene editing and deployment contexts. The The framework combines constrained optimization refinement, probabilistic uncertainty modeling, and adaptive regulatory planning to provide a structured basis for compliance aware and context sensitive decision support. Results and discussion: Experimental results on the evaluated datasets indicate that the ARO achieves improved performance on the selected metrics relative to the compared methods, while its architecture is explicitly designed to integrate regulatory constraints into the optimization process. These findings suggest that the proposed framework provides a promising foundation for supporting more transparent, adaptive, and analytically grounded decision making in CRISPR Cas applications for crop biotechnology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.